Drilldown: Medicines
Medicines > classes 
:
Anticonvulsant or
Neuroleptic or
Selective 5HT2A inverse agonist (with weaker 5HT2C inverse agonism)
:
Anticonvulsant or
Neuroleptic or
Selective 5HT2A inverse agonist (with weaker 5HT2C inverse agonism) Use the filters below to narrow your results.
generic:
None (1) ·
Asenapine (1) ·
Brivaracetam (1) ·
Cannabidiol (1) ·
Cenobamate (1) ·
Chlorpromazine (1) ·
Clobazam (1) ·
Droperidol (1) ·
Eslicarbazepine (1) ·
Ethosuximide (1) ·
Felbamate (1) ·
Fenfluramine (1) ·
Fluphenazine (1) ·
Fosphenytoin (1) ·
Iloperidone (1) ·
Lacosamide (1) ·
Loxapine (1) ·
Lurasidone (1) ·
Molindone (1) ·
Paliperidone (1) ·
Perampanel (1) ·
Perphenazine (1) ·
Phenobarbital (1) ·
Phenytoin (1) ·
Pimozide (1) ·
Rufinamide (1) ·
Stiripentol (1) ·
Thioridazine (1) ·
Thiothixene (1) ·
Tiagabine (1) ·
Trifluoperazine (1) ·
Valproic acid (1) ·
Vigabatrin (1) ·
Ziprasidone (1) ·
Zonisamide (1)
brand:
Aptiom (1) ·
Banzel (1) ·
Briviact (1) ·
Cerebyx (1) ·
Depakote (1) ·
Diacomit (1) ·
Dilantin (1) ·
Epidiolex (1) ·
Fanapt (1) ·
Felbatol (1) ·
Fintepla (1) ·
Fycompa (1) ·
Gabitril (1) ·
Geodon (1) ·
Inapsine (1) ·
Invega (1) ·
Latuda (1) ·
Loxitane (1) ·
Luminal (1) ·
Mellaril (1) ·
Moban (1) ·
Navane (1) ·
Nuplazid (1) ·
Onfi (1) ·
Orap (1) ·
Prolixin (1) ·
Sabril (1) ·
Saphris (1) ·
Stelazine (1) ·
Thorazine (1) ·
Trilafon (1) ·
Vimpat (1) ·
Xcopri (1) ·
Zarontin (1) ·
Zonegran (1)
classes: (Click arrow to add another value)
mechanism:
AMPA receptor antagonist (1) ·
Butyrophenone D2 antagonist (1) ·
D2 receptor antagonist; also H1, alpha-1, muscarinic antagonist (1) ·
D2/5-HT2A antagonist (1) ·
D2/5-HT2A antagonist; 5-HT7 antagonist (1) ·
D2/5-HT2A antagonist; active metabolite of risperidone (1) ·
D2/5-HT2A antagonist; SRI and NRI (1) ·
Dibenzoxazepine D2/5-HT2 antagonist (1) ·
Dihydroindolone D2 antagonist (1) ·
Diphenylbutylpiperidine D2 antagonist (1) ·
GABA enhancer; sodium channel blocker; histone deacetylase inhibitor (1) ·
GABA reuptake inhibitor (GAT-1 blocker) (1) ·
GABAA positive allosteric modulator (1) ·
GABAA positive allosteric modulator; lactate dehydrogenase inhibitor (1) ·
GABAA potentiator and direct activator (1) ·
Irreversible GABA-T inhibitor (1) ·
Multi-receptor antagonist (D2, 5-HT2A, H1, alpha) (1) ·
Multiple mechanisms; GPR55 antagonist; TRPV1 agonist (1) ·
NMDA antagonist; GABAA potentiator (1) ·
Phenothiazine D2 antagonist (4) ·
Prodrug of phenytoin; sodium channel blocker (1) ·
Selective inverse agonist at 5HT2A receptors with weaker activity at 5HT2C. Has no significant dopamine D2 affinity, unique among approved antipsychotics. Inverse agonism (rather than antagonism) reduces constitutive 5HT2A receptor activity below baseline. (1) ·
Serotonin releaser; sigma-1 agonist (1) ·
Slow-inactivation sodium channel enhancer; CRMP-2 ligand (1) ·
Sodium channel blocker (2) ·
Sodium channel blocker; GABAA positive allosteric modulator (1) ·
Sodium channel modulator (1) ·
Sodium/T-type calcium channel blocker; carbonic anhydrase inhibitor (1) ·
SV2A ligand (higher affinity than levetiracetam) (1) ·
T-type calcium channel blocker (1) ·
Thioxanthene D2 antagonist (1)
uses:
starting dose:
preparations:
fda max:
duration:
bioavailability:
pregnancy:
Showing below up to 35 results in range #1 to #35.